Read Time:6 Second
Medicare has reached a preliminary decision to cover Biogen’s Alzheimer’s drug, Aduhelm, for patients who are in approved clinical trials.
Medicare has reached a preliminary decision to cover Biogen’s Alzheimer’s drug, Aduhelm, for patients who are in approved clinical trials.
Average Rating
More Stories
Entertainment/ Sports Almanac for 1950
Entertainment/ Sports Almanac for 1951
Entertainment/ Sports Almanac for 1952